Tara O. Henderson | |
---|---|
Academic background | |
Education | MD, Pritzker School of Medicine MPH, 2005, Harvard T.H. Chan School of Public Health |
Academic work | |
Institutions | University of Chicago University of Chicago Medical Center |
Tara Olive Henderson is an American pediatric oncologist. As the Arthur and Marian Edelstein Professor in the Department of Pediatrics,she is also the Director of the Childhood Cancer Survivor Center,Director of Survivorship at the University of Chicago Comprehensive Cancer Center,and chief of Pediatric Hematology and Oncology at the University of Chicago.
Henderson became interested in the field of oncology after spending a summer in a New Jersey cancer research lab through a program called Partners in Science. [1] Henderson completed her medical degree at the Pritzker School of Medicine and her Master of Public Health at the Harvard T.H. Chan School of Public Health. Following her medical degree,Henderson completed her fellowship at Boston Children's Hospital and her residency at Johns Hopkins School of Medicine. [2] After finishing her master's degree at Harvard,Henderson received the 2005 Conquer Cancer Foundation Merit Award for her research on sarcomas as a subsequent malignancy in survivors of pediatric cancer,conducted as part of the Childhood Cancer Survivor Study. [3]
Following her master's degree at Harvard,Henderson joined the Department of Pediatrics within the hematology-oncology section at the University of Chicago's (UChicago) Pritzker School of Medicine. [4] By 2016,Henderson was serving as the Director of the Childhood Cancer Survivors Center where she specialized in care for childhood cancer survivors. [5] Outside of UChicago,Henderson was appointed to serve on the 2017–18 Board of Directors for the American Society of Clinical Oncology (ASCO). [6] She was also selected for 2018 Presidential Leadership Scholars program to help her develop practical leadership skills. [3] Following this program,Henderson was designated ASCO's pediatric oncologist on its board of directors for a four-year term. [7]
During the COVID-19 pandemic,Henderson publicly advocated to dispel vaccine hesitancy and encouraged other healthcare workers to receive the COVID-19 vaccine. [8] In October 2021,Henderson re-appeared in Chicago magazine's Top Doctors and Top Doctors for Moms and Kids lists. [9] Later,she was elected a Member of the American Society for Clinical Investigation for her efforts to addresses the late outcomes of childhood,adolescent and young adult cancer to inform both new treatment paradigms and long-term follow up care. [10] In November 2021,Henderson was appointed the Service Line Chief of Pediatric Cancer and Blood Diseases at the Chicagoland Children's Health Alliance. She also became the Section Chief of Pediatric Hematology/Oncology and Stem Cell Transplantation at UChicago Medicine at the University of Chicago Medical Center. [11] The following year,Henderson was named the Arthur and Marian Edelstein Professor in the Department of Pediatrics at UChicago. [12]
Henderson is married and has three children. [3]
Olufunmilayo I. Olopade born in the year 1957,is a Nigerian hematology oncologist,Associate Dean for Global Health and Walter L. Palmer,Distinguished Service Professor in Medicine and Human Genetics at the University of Chicago. She also serves as director of the University of Chicago Hospital's Cancer Risk Clinic.
Childhood cancer is cancer in a child. About 80% of childhood cancer cases in high-income countries,can be successfully treated thanks to modern medical treatments and optimal patient care. However,only about 10% of children diagnosed with cancer reside in high-income countries where the necessary treatments and care is available. Childhood cancer represents only about 1% of all types of cancers diagnosed in children and adults. For this reason,childhood cancer is often ignored in control planning,contributing to the burden of missed opportunities for its diagnoses and management in countries that are low- and mid-income.
Patrick Schöffski is a German medical doctor specializing in internal medicine,hematology and medical oncology.
Jaume Mora is a Spanish physician and researcher specialized in pediatric cancer.
Ashok K. Vaid is an Indian medical oncologist,known for his pioneering efforts in bone marrow transplantation in India. He is credited with the performance of the first 25 bone marrow transplantations in the private sector in North India. He heads the Cancer Institute- Division of Medical Oncology and Haemotology at Medanta The Medicity.
Holger Lode is a German specialist for pediatrics. He is Professor and Chair of the Department of General Pediatrics and Pediatric Hematology and Oncology at the University Medicine Greifswald. He is also the director of the Center of Pediatrics and Adolescent Medicine in Greifswald. Lode is well known for his clinical and scientific work on immunotherapy of neuroblastoma.
Olga Aleinikova —is a pediatric-oncohematologist,PhD,Doctor of Medical Science (1999),Professor (2003),Corresponding Member of the National Academy of Sciences of Belarus,Director of State Institution "Belarusian Research Center for Pediatric Oncology,Hematology and Immunology".
Teresa J. Vietti was an American physician. She is best known for her pioneering work and research in pediatric cancer. Her research discovered the genetics of leukemia,new chemotherapy agents and tracked the effects of chemotherapy on childhood cancer survivors. Vietti also wrote about her research and was an editor of the Journal of Pediatric Hematology and a co-editor of Clinical Pediatric Oncology. According to Washington University in St. Louis,she was known as "the mother of pediatric cancer therapy."
Crystal L. Mackall is an American physician and immunologist. She is currently the Ernest and Amelia Gallo Family Professor of Pediatrics and Medicine at Stanford University. She is the founding director of the Stanford Center for Cancer Cell Therapy.
Susan Lerner Cohn is a professor of pediatrics and section chief of oncology and hematopoietic stem cell transplantation at the Pritzker School of Medicine of the University of Chicago. She is recognized for her contributions to pediatric oncology research.
Jonathan Lester Finlay is a pediatric neuro-oncologist specializing in the management of children,adolescents and young adults with brain tumors. He is the director of Neuro-oncology at Nationwide Children's Hospital,where he also serves as the Elizabeth and Richard Germain Endowed Chair in Pediatric Cancer. He also is professor of pediatrics at The Ohio State University College of Medicine.
The University of Chicago Comer Children's Hospital (UC CCH) formerly University of Chicago Children's Hospital is a nationally ranked,freestanding,172-bed,pediatric acute care children's hospital adjacent to University of Chicago Medical Center. It is affiliated with the University of Chicago Pritzker School of Medicine and is a member of the UChicago health system,the only children's hospital in the system. The hospital provides comprehensive pediatric specialties and subspecialties to infants,children,teens,and young adults aged 0–21 throughout Chicago and features an ACS verified level I pediatric trauma center. Its regional pediatric intensive-care unit and neonatal intensive care units serve the Chicago region.
Nirali N. Shah is an American physician-scientist and pediatric hematologist-oncologist,serving as head of the hematologic malignancies section of the pediatric oncology branch at the National Cancer Institute. She researches the translation of immunotherapeutic approaches to treat high-risk hematologic malignancies in children,adolescents and young adults.
James R. Downing is an American clinical executive. He is the president and chief executive officer of St. Jude Children's Research Hospital.
Stephen Patrick Hunger is an American pediatric oncologist. He is the Chief of the Division of Oncology,Director of the Center for Childhood Cancer Research,and holder of the Jeffrey E. Perelman Distinguished Chair in the Department of Pediatrics at the Children's Hospital of Philadelphia (CHOP).
Michael P. Link is an American oncologist. He is the Lydia J. Lee Professor of Pediatric Hematology/Oncology at Stanford University School of Medicine.
Everett E. Vokes is an American oncologist. He is the John E. Ultmann Professor,chair of the Department of Medicine,and physician-in-chief at the University of Chicago Medical Center. In this role,he pioneered the combination radiation and chemotherapy as first-line treatment for head and neck cancer.
Sonali Mehta Smith is an American oncologist. She is the Elwood V. Jensen Professor and Chief of the Hematology/Oncology Section at the University of Chicago.
Julie Ann Panepinto is an American pediatric hematologist-oncologist and physician-scientist. She specializes in health outcomes research and sickle cell disease. Panepinto became the acting director of the division of blood diseases and resources at the National Heart,Lung,and Blood Institute in 2022. She was a professor of pediatrics and hematology at the Medical College of Wisconsin.
Smita Bhatia is an Indian-born American oncologist. She is the Director of the Institute for Cancer Outcomes and Survivorship in the University of Alabama at Birmingham School of Medicine,as well as the Vice Chair for Outcomes in the Department of Pediatrics and Senior Advisor for Cancer Outcomes Research at the O'Neal Comprehensive Cancer Center at UAB.